Mauricio Tohen, MD, DrPH, MBA
Department of Psychiatry & Behavioral Sciences, University of New Mexico, Albuquerque, New Mexico
ASCP Corner
When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?
August 6, 2026
Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may...
Academic Highlights
Identifying Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic
June 16, 2020
In this article focusing on maintenance treatment of bipolar I disorder, experts discuss functional impairment, the potential for LAI antipsychotics to address nonadherence, and the characteristics of patients who...
Consensus Statement
Screening, Diagnosis, and Treatment of Tardive Dyskinesia
January 28, 2020
Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
Article
Patient Characteristics With Antipsychotic Treatment
June 1, 2017
How does lurasidone compare to other atypical antipsychotics for treatment of bipolar disorder? This study assessed background characteristics, comorbidities, prior health care utilization, and costs for patients with bipolar...
